- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 255/00 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups
Patent holdings for IPC class C07D 255/00
Total number of patents in this class: 16
10-year publication summary
|
0
|
0
|
0
|
1
|
0
|
2
|
1
|
0
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America as represented by the Secretary of the Navy | 2798 |
5 |
| Boehringer Ingelheim International GmbH | 4644 |
2 |
| Merck Sharp & Dohme Corp. | 2190 |
1 |
| Massachusetts Institute of Technology | 10124 |
1 |
| Children's Medical Center Corporation | 1909 |
1 |
| GE Healthcare AS | 221 |
1 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 29 |
1 |
| Humanwell Healthcare (Group) Co., Ltd. | 40 |
1 |
| Beijing Innocare Pharma Tech Co., Ltd. | 92 |
1 |
| Biohaven Therapeutics Ltd. | 109 |
1 |
| Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | 126 |
1 |
| Other owners | 0 |